ArticleMagma (New York, N.Y.)2023
Radiomics-based machine-learning method to diagnose prostate cancer using mp-MRI: a comparison between conventional and fused models.
Article in Magma (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 10 citations in OpenAlex.
- Predicting distant metastasis in early-onset kidney cancer using machine learning: a SEER database study with external validation.Clinical and experimental medicine · 2025Article
- Radiomic Pipelines for Prostate Cancer in External Beam Radiation Therapy: A Review of Methods and Future Directions.Journal of clinical medicine · 2024Review
- Artificial Intelligence in the Diagnosis and Treatment of Pancreatic Cystic Lesions and Adenocarcinoma.Cancers · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesMultiparametric MRI (mp-MRI) has been significantly used for detection, localization and staging of Prostate cancer (PCa). However, all the assessment suffers from poor reproducibility among the readers. The aim of this study was to evaluate radiomics models to diagnose PCa using high-resolution T2-weighted (T2-W) and dynamic contrast-enhanced (DCE) MRI. MATERIALS AND
methodsThirty two patients who had high prostate specific antigen level were recruited. The prostate biopsies considered as the reference to differentiate between 66 benign and 36 malignant prostate lesions. 181 features were extracted from each modality. K-nearest neighbors, artificial neural network, decision tree, and linear discriminant analysis were used for machine-learning study. The leave-one-out cross-validation method was used to prevent overfitting and build robust models.
resultsRadiomics analysis showed that T2-W images were more effective in PCa detection compare to DCE images. Local binary pattern features and speeded up robust features had the highest ability for prediction in T2-W and DCE images, respectively. The classifier fusion using decision template method showed the highest performance with accuracy, specificity, and sensitivity of 100%. DISCUSSION: The findings of this framework provide researchers on PCa with a promising method for reliable detection of prostate lesions in MR images by fused model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.